Clinically, PD-L1 upregulation via IFN-γ-JAK-STAT was more frequently observed in patients with larger CRC that were positive for vascular or lymphatic infiltration and poorly differentiated, in correlation to poor survival [112]. The gene discussed is IFNG; the disease is colorectal carcinoma.